NOVIXPEN Articles

Insulin Pen Manufacturer Selection: What Sets a Supplier Apart

Published 2026-10-28 · Keywords: insulin pen manufacturer

An insulin pen manufacturer earns a pharmaceutical program on four things: dose accuracy that survives ISO 11608-1 testing across the full dial range, cartridge interfaces verified against your named supplier, a quality system whose certificate scope names finished devices, and documentation your RA team can file without rework. Price ranks fifth — an insulin pen is a daily-use chronic device, and accuracy failures cost more than any unit-price saving.

Reusable, disposable, or both?

Most insulin pen manufacturer portfolios split into three architectures, and mature suppliers offer all of them:

Platform Dose behaviour Best for NOVIXPEN example
Reusable adjustable Dial per injection, cartridge replaced Long-term basal/bolus users WH-RG (5 mL cartridge), A-60 (1–60 IU)
Disposable adjustable Fixed cartridge count, dial per injection Course-based or turnover-heavy markets A-75 (1–75 IU), multi-dose WH-DG
Fixed-dose prefilled No dialling Simplicity-first markets, travel pens WH-DF prefilled syringe platform

A supplier who can quote all three from one quality system saves you a second qualification cycle when your portfolio grows.

The verification questions that sort suppliers fast

  1. Scope text: quote your ISO 13485 scope verbatim — does it cover finished pen injectors? (Ours, TÜV SÜD: “Design and Development, Production and Distribution of Pen Injector, Disposable Pen Injector”.)
  2. Accuracy report: does the ISO 11608-1 dose-accuracy report cover the lowest dial step, not just mid-range?
  3. Cartridge interface: will you verify compatibility against our named cartridge supplier before the order, with force-chain numbers?
  4. MDSAP evidence: which regulators does your audit cover — TGA, ANVISA, Health Canada, PMDA, FDA?

A supplier who answers all four in writing has done this before. One who answers “yes we have ISO” has not.

What this does not cover

The devices ship empty and contain no drug — no therapeutic claims; insulin references are dosing-profile examples. Formulation, stability and clinical decisions belong to your team.

Next step: send your cartridge format, dose range and target markets — we return the platform match, the compliance scope in writing and a written quotation within one working day. Start the inquiry.

Talk to NOVIXPEN about your program

Send your container format, annual volume and target market — we reply with the platform match, documentation set and written quotation within one working day.

Start the inquiry